ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025

ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025

The Program Includes

  • 3 high quality plenary lectures
  • 9 sessions on key topics in Medicinal Chemistry
  • About 18 oral communications selected from the submitted abstracts
  • An extensive social program to maximise your networking opportunities
  • A poster session and a commercial exhibition

The event attracts a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, drug metabolism and pharmacokinetics (DMPK), pharmacology, and early toxicology.

The 2025 edition is chaired by Prof. Terry W. Moore, University of Illinois, Chicago, IL, USA.

 

Plenary Lectures

Designing Impactful Drugs

Dr Ingo Hartung
MERCK Healthcare, Darmstadt, Germany

New Strategies for Anticancer and Antibacterial Drug Discovery

Prof. Paul J. Hergenrother
University of Illinois, Urbana, United States

Title to be announced

Dr Wendy Young
Biotech Executive & Independent Board Member, San Francisco, CA, United States

Invited Lectures

Prof. Erden Banoglu
GAZI University, Ankara, Turkey

Dr Aaron Coffin
ATAVISTIK Bio, Cambridge, United States

Dr Barbara Czako
NURIX, San Francisco, CA

Dr Amanda Dombrowski
ABBVIE, North Chicago, United States

Event Details

Leave a Reply

Kindly review our community guidelines before leaving a comment.

Your email address will not be published. Required fields are marked *